Assessing quality of life in pediatric fibrous dysplasia and McCune Albright syndrome: PEDS-QL and HADS data from the Fibrous Dysplasia Foundation Patient Registry
-
Published:2021-04-12
Issue:1
Volume:5
Page:
-
ISSN:2509-8020
-
Container-title:Journal of Patient-Reported Outcomes
-
language:en
-
Short-container-title:J Patient Rep Outcomes
Abstract
Abstract
Purpose
The International FD/MAS Consortium recently encouraged using the Pediatric Quality of Life Inventory (PEDS-QL) and the Hospital Anxiety and Depression scales (HADS) in clinical care. This study examines scores on these measures among pediatric fibrous dysplasia and McCune Albright (FD/MAS) patients to initiate consideration of their use in clinical treatment.
Methods
This is a retrospective analysis of pediatric data from 39 minors, ages 2–17, entered in the Fibrous Dysplasia Foundation Patient Registry from July 2016 to December 2018. Sample means and score distributions are compared to general population and chronic disease benchmarks. Associations with medical and demographic variables are also explored.
Results
Mean PEDS-QL scores for children 2–7 were inconclusive in determining at risk status for impaired quality of life (QOL). Individual score distributions suggested up to half experienced extensive physical or social impairment. Means and individual score distributions for the physical and psychosocial components of the PEDS-QL for children 8–17 suggested many were at risk of impaired QOL. Over half of 13–17 year-olds met the clinical benchmark for anxiety. Older males scored better than females on the PEDS-QL and HADS. Pain frequency was associated with physical function for older children.
Conclusions
Older children with FD/MAS may be more compromised in terms of psychosocial QOL than previously reported. Clinicians should be attentive to the influence of gender on QOL in older children. Online patient registries associated with rare diseases have the potential to serve as efficient and cost-effective mechanisms to jumpstart examination of new measures in consideration for clinical use.
Funder
Oral and Maxillofacial Surgery Foundation
Publisher
Springer Science and Business Media LLC
Subject
Health Information Management,Health Informatics
Reference48 articles.
1. Boyce, A. M., Florenzano, P., de Castro, L. F., & Collins, M. T. (2015). [Updated 2019 Jun 27]. In: M. P. Adam, H. H. Ardinger, R. A. Pagon, et al., (Eds.), GeneReviews® [Internet] (pp. 1993-2020). Seattle: University of Washington, Seattle. 2. Kushchayeva, Y. S., Kushchayev, S. V., Glushko, T. Y., Tella, S. H., Teytelboym, O. M., Collins, M. T., & Boyce, A. M. (2018). Fibrous dysplasia for radiologists: Beyond ground glass bone matrix. Insights Imaging, 9(6), 1035–1056. https://doi.org/10.1007/s13244-018-0666-6. 3. Javaid, M. K., Boyce, A., Appelman-Dijkstra, N., Ong, J., Defabianis, P., Offiah, A., et al. (2019). Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet Journal of Rare Diseases, 14, 139. 4. Utriainen, P., Valta, H., Björnsdottir, S., Mäkitie, O., & Horemuzova, E. (2018). Polyostotic fibrous dysplasia with and without McCune–Albright syndrome—Clinical features in a Nordic pediatric cohort. Frontiers in Endocrinology, 9, 96. https://doi.org/10.3389/fendo.2018.00096. 5. Konradi, A. (2017). Treating the “illness” of Cherubism and craniofacial fibrous dysplasia: Addressing the stigma of craniofacial difference. The Journal of Law, Medicine & Ethics, 45(4), 582–595. https://doi.org/10.1177/1073110517750598.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|